Go Pro
Allen Gong

Allen Gong Analyst Performance

Vice President, Equity Research at JPMorgan Chase & Co.

Allen Gong is a stock analyst at JPMorgan Chase & Co. in the healthcare sector, covering 6 publicly traded companies. Over the past year, Allen Gong has issued 13 stock ratings, including buy and hold recommendations. While full access to Allen Gong's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Allen Gong's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
14 Last 1 Years
Buy Recommendations
78.57% 11 Buy Ratings
Companies Covered
6 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy78.6%11 ratings
Hold21.4%3 ratings
Sell0.0%0 ratings

Out of 14 total stock ratings issued by Allen Gong at JPMorgan Chase & Co., the majority (78.6%) have been Buy recommendations, followed by 21.4% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
66.7% of companies on NASDAQ
4 companies
NYSE
33.3% of companies on NYSE
2 companies

Allen Gong, an analyst at JPMorgan Chase & Co., currently covers 6 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
6 companies
100.0%

Allen Gong of JPMorgan Chase & Co. specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
HEALTHCARE EQUIPMENT & SUPPLIES
6 companies
100.0%

Allen Gong's Ratings History at JPMorgan Chase & Co.

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
8/7/2026Boost Price Target$79.35$95.00Overweight
Haemonetics Corporation stock logo
HAE
Haemonetics
8/7/2026Boost Price Target$85.72$86.00Neutral
Haemonetics Corporation stock logo
HAE
Haemonetics
5/8/2026Lower Price Target$55.36$62.00Neutral
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
5/6/2026Lower Price Target$6.99$16.00Overweight
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
5/1/2026Lower Price Target$118.39$175.00Overweight
Glaukos Corporation stock logo
GKOS
Glaukos
4/30/2026Boost Price Target$142.95$140.00Overweight
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
2/25/2026Boost Price Target$133.26$149.00Neutral
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
2/20/2026Lower Price Target$150.42$215.00Overweight
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
12/17/2025Boost Price Target$74.20$80.00Overweight
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
11/6/2025Boost Price Target$64.91$71.00Overweight
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
10/31/2025Boost Price Target$187.40$240.00Overweight
Glaukos Corporation stock logo
GKOS
Glaukos
10/30/2025Boost Price Target$88.21$120.00Overweight
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
10/24/2025Initiated Coverage$15.89$19.00Overweight
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
8/1/2025Boost Price Target$167.16$190.00Overweight